Venus Remedies

Part of MojoOne Strategy

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE411B01019
NSEID: VENUSREM
BSEID: 526953

INR

769.00

-28.15 (-3.53%)

BSENSE

Dec 17

BSE+NSE Vol: 34.6 k

Click here to access the older version

{
  "main_header": {
    "sid": 568580,
    "name": "Venus Remedies",
    "stock_name": "Venus Remedies",
    "full_name": "Venus Remedies Ltd",
    "name_url": "stocks-analysis/venus-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "769.00",
    "chg": -28.15,
    "chgp": "-3.53%",
    "dir": -1,
    "prev_price": "797.15",
    "mcapval": "1,024.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526953,
    "symbol": "VENUSREM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE411B01019",
    "curr_date": "Dec 17",
    "curr_time": "",
    "bse_nse_vol": "34.6 k",
    "exc_status": "Active",
    "traded_date": "Dec 17, 2025",
    "traded_date_str": "2025 12 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3758809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3758809.png",
        "date": "2025-12-15 14:00:10",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 15 Dec 2025 as the stock hit its lower circuit limit, reflecting intense selling pressure and a significant intraday loss of 5.0%. The stock’s performance notably underperformed its sector and the broader market, signalling heightened investor caution and unfilled supply at lower price levels."
      },
      {
        "title": "Venus Remedies Stock Hits All-Time High at Rs.839, Marking a Milestone in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-stock-hits-all-time-high-of-rs839-on-12-dec-2025-3757363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3757363.png",
        "date": "2025-12-12 10:34:57",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.839 today, underscoring a remarkable trajectory of growth and resilience in a competitive market environment."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.839, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-at-rs839-marking-strong-momentum-3757328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3757328.png",
        "date": "2025-12-12 10:19:17",
        "description": "Venus Remedies has reached a new 52-week high of Rs.839, reflecting a strong rally in the Pharmaceuticals & Biotechnology sector. This milestone highlights the stock’s sustained momentum, supported by robust financial performance and favourable market conditions."
      },
      {
        "title": "Why is Venus Remedies falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venus-remedies-fallingrising-3756857",
        "imagepath": "",
        "date": "2025-12-12 01:02:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Exceptional Returns Outpacing Benchmarks</strong></p>\n<p>Venus Remedies has demonstrated remarkable returns over multiple time horizons, far exceeding the performance of the Sensex benchmark. Over the past week, the stock gained 9.68%, while the Sensex declined by 0.52%. The momentum extends over longer periods, with a one-month return of 55.74% compared to the Sensex’s modest 1.13%. Year-to-date, Venus Remedies has surged 162.03%, dwarfing the Sensex’s 8.55% gain. Even over one, three, and five years, the stock’s returns of 142.88%, 332.47%, and 480.32% respectively, significantly outpace the Sensex’s 4.04%, 36.40%, and 83.99%.</p>\n<p>This sustained outperformance underscores strong investor confidence and suggests that the company’s fundamentals or market positioning may be driving substan..."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.825, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-at-rs825-marking-strong-momentum-3756190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3756190.png",
        "date": "2025-12-11 09:54:10",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.825 today, underscoring a notable phase of momentum in the stock’s performance. This milestone reflects a sustained upward trend supported by robust financial metrics and market dynamics."
      },
      {
        "title": "Venus Remedies Emerges as a Multibagger Stock with Exceptional Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-a-multibagger-pharma-stock-delivering-exceptional-returns-3756122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_multibagger_3756122.png",
        "date": "2025-12-11 09:40:07",
        "description": "Venus Remedies Ltd has delivered remarkable returns over multiple time horizons, firmly establishing itself as a multibagger stock within the Pharmaceuticals & Biotechnology sector. The company’s performance has significantly outpaced benchmark indices, reflecting robust financial growth and operational strength."
      },
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3753488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3753488.png",
        "date": "2025-12-09 10:00:16",
        "description": "Venus Remedies Ltd witnessed a sharp decline on 9 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed near the day’s low, reflecting a maximum daily loss of 4.96%, signalling panic selling and a significant imbalance between supply and demand."
      },
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3746619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3746619.png",
        "date": "2025-12-04 11:00:12",
        "description": "Venus Remedies Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹770.0, marking a maximum daily loss and signalling a wave of panic selling that left a significant portion of supply unfilled in the market."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.808.5, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-of-rs8085-marking-significant-milestone-3746120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3746120.png",
        "date": "2025-12-04 10:02:43",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally in its stock price. This milestone reflects sustained momentum driven by strong financial performance and favourable market conditions."
      }
    ],
    "total": 306,
    "sid": "568580",
    "stock_news_url": "https://www.marketsmojo.com/news/venus-remedies-568580"
  },
  "announcements": [
    {
      "caption": "Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies Limited.",
      "datetime": "13-Dec-2025",
      "details": "Social media Post",
      "source": "BSE"
    },
    {
      "caption": "Shares Re-Lodged For Transfer Cum Demat Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod/P/CIR/2025/97 Dated July 2 2025 For The Period July 7 2025 To November 30 2025",
      "datetime": "12-Dec-2025",
      "details": "Status of Physical Transfer request.",
      "source": "BSE"
    },
    {
      "caption": "Venus Remedies Marks Completion Of AMR Licensing Milestones With Final ?11 Crore Payment",
      "datetime": "08-Dec-2025",
      "details": "Announcement as per captioned subject.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Venus Remedies Ltd has declared <strong>30%</strong> dividend, ex-date: 23 Sep 13",
          "dt": "2013-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-15 14:00:10

Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 15 Dec 2025 as the stock hit its lower circuit limit, reflecting intense selling pressure and a significant intraday loss of 5.0%. The stock’s performance notably underperformed its sector and the broader market, signalling heightened investor caution and unfilled supply at lower price levels.

Venus Remedies Stock Hits All-Time High at Rs.839, Marking a Milestone in Pharmaceuticals Sector

2025-12-12 10:34:57

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.839 today, underscoring a remarkable trajectory of growth and resilience in a competitive market environment.

Venus Remedies Hits New 52-Week High of Rs.839, Marking Significant Milestone

2025-12-12 10:19:17

Venus Remedies has reached a new 52-week high of Rs.839, reflecting a strong rally in the Pharmaceuticals & Biotechnology sector. This milestone highlights the stock’s sustained momentum, supported by robust financial performance and favourable market conditions.

Why is Venus Remedies falling/rising?

2025-12-12 01:02:16

Exceptional Returns Outpacing Benchmarks

Venus Remedies has demonstrated remarkable returns over multiple time horizons, far exceeding the performance of the Sensex benchmark. Over the past week, the stock gained 9.68%, while the Sensex declined by 0.52%. The momentum extends over longer periods, with a one-month return of 55.74% compared to the Sensex’s modest 1.13%. Year-to-date, Venus Remedies has surged 162.03%, dwarfing the Sensex’s 8.55% gain. Even over one, three, and five years, the stock’s returns of 142.88%, 332.47%, and 480.32% respectively, significantly outpace the Sensex’s 4.04%, 36.40%, and 83.99%.

This sustained outperformance underscores strong investor confidence and suggests that the company’s fundamentals or market positioning may be driving substan...

Venus Remedies Hits New 52-Week High of Rs.825, Marking Significant Milestone

2025-12-11 09:54:10

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.825 today, underscoring a notable phase of momentum in the stock’s performance. This milestone reflects a sustained upward trend supported by robust financial metrics and market dynamics.

Venus Remedies Emerges as a Multibagger Stock with Exceptional Returns

2025-12-11 09:40:07

Venus Remedies Ltd has delivered remarkable returns over multiple time horizons, firmly establishing itself as a multibagger stock within the Pharmaceuticals & Biotechnology sector. The company’s performance has significantly outpaced benchmark indices, reflecting robust financial growth and operational strength.

Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-09 10:00:16

Venus Remedies Ltd witnessed a sharp decline on 9 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed near the day’s low, reflecting a maximum daily loss of 4.96%, signalling panic selling and a significant imbalance between supply and demand.

Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-04 11:00:12

Venus Remedies Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹770.0, marking a maximum daily loss and signalling a wave of panic selling that left a significant portion of supply unfilled in the market.

Venus Remedies Hits New 52-Week High of Rs.808.5, Marking Significant Milestone

2025-12-04 10:02:43

Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally in its stock price. This milestone reflects sustained momentum driven by strong financial performance and favourable market conditions.